The Technical Analyst
ALPS Medical [SBIO]
Exchange: NYSE Sector: Real Estate
ALPS Medical Price, Forecast, Insider, Ratings, Fundamentals & Signals
-1.34% $34.35
America/New_York / 8 mai 2024 @ 15:50
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 104.23 mill |
| EPS: | 0 |
| P/E: | 0 |
| Earnings Date: | N/A |
| SharesOutstanding: | 3.03 mill |
| Avg Daily Volume: | 0.0127 mill |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE 30.55 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE 13.52 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 33.63 - 35.07 ( +/- 2.10%) |
| ATR Model: 14 days |
Forecast:
16:00 - $34.35
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $34.35
Forecast 2: 16:00 - $34.35
Forecast 3: 16:00 - $34.35
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $34.35 (-1.34% ) |
| Volume | 0.0070 mill |
| Avg. Vol. | 0.0127 mill |
| % of Avg. Vol | 55.22 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For SBIO
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
SBIO
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
Latest Press Releases
2023-09-24 10:23:00 - Press Release
Vector Space Biosciences (sbio) Is Now Available For Trading On Lbank Exchange
Road town, virgin islands--(newsfile corp. - september 24, 2023) - lbank exchange, a global digital asset trading platform, listed vector space biosciences (sbio) on september 15, 2023. for all users of lbank exchange, the sbio/usdt trading pair is now officially available for trading.
Latest News
2024-05-07 12:17:02 - ETF Trends
Biopharma R&D Trends Could Bode Well for This ETF
Many investors hoping for a resurgence by biotech stocks have hitched their wagons to the Federal Reserve lowering interest rates. That's a practical bet because biotech is a rate-sensitive industry.
2024-02-06 11:07:25 - ETF Trends
There Could Be Signs of Life for Biotech ETFs
Biotech stocks and exchange traded funds have endured a lengthy rough patch. And the pain has been particularly acute for small- and mid-cap fare.
2024-01-17 14:01:21 - Zacks Investment Research
Inside Small-Cap's 3-Year Best Surge in Popularity: ETFs in Focus
Wall Street's newfound bullishness on small caps reflects a notable shift in market dynamics, with several analysts predicting continued growth.
2024-01-08 10:49:39 - ETF Trends
What's Now Inside Some Fundamentally Focused ETFs
Many of us were prepping for year-end (or on vacation in Belize, in my case) in December. However, index providers were hard at work to ensure certain ETFs fully reflected the investment criteria advisors have come to expect.
2023-12-29 12:46:32 - Zacks Investment Research
5 Market-Beating Sector ETFs of December
Wall Street sizzled in December, with all three major indices touching a series of new highs.
2023-12-28 13:40:52 - ETF Trends
Biotech ETF SBIO's Momentum Strong to End 2023
With the year drawing to a closer, investors may be on the lookout for a strategy or idea that has some momentum. In a notable turnaround from earlier this year, biotech looks to be one such area to consider.
2023-12-14 08:12:43 - ETF Trends
Biotech ETF SBIO Sees Buy Signal Amid Hot Returns
It's been a complicated year for tech firms outside those “Magnificent Seven” names that have, to some degree, outgrown a simple “tech” distinction. High interest rates have taken a toll on tech firms.
2023-12-11 14:17:03 - Zacks Investment Research
Best-Performing ETFs of Last Week
The S&P 500 hit a new high for the year last week after the November jobs report and University of Michigan consumer survey data indicated a resilient economy and cooling inflation, triggering bets on a so-called soft-landing scenario.
2023-12-07 15:43:41 - ETF Trends
Play US Gene Treatment Approval in SBIO
Tech has been a big driver of market resilience this year, with AI specifically boosting earnings for all kinds of companies. That said, technology isn't just moving forward in software.
2023-10-31 11:28:49 - ETF Trends
Innovation Could Propel Biotechnology Bounce
Biotechnology is certainly on the list, if not at the top, of high-growth industries in dire need of a rebound. Following enthusiasm for COVID-19 vaccines in late 2020 and part of 2021, biotechnology stocks and ETFs have disappointed investors.